Photo by atikahakhtar from unsplash
Patients and physicians may be concerned about starting a biologic treatment during the COVID-19 pandemic. Whether biologics enhance the risk of being infected with SARS-CoV-2 or if the disease course… Click to show full abstract
Patients and physicians may be concerned about starting a biologic treatment during the COVID-19 pandemic. Whether biologics enhance the risk of being infected with SARS-CoV-2 or if the disease course is worsened, remain to be ascertained. So far, no negative signal emerged for an increased risk of severe COVID-19 associated with biologics when compared with the general population.
Keywords:
cov screening;
test indicated;
screening test;
psoriasis patients;
sars cov;
indicated psoriasis
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!